LIKARDA LLC
Kansas City, KS · Biotech · Private
Encapsulated insulin-producing pluripotent stem cells using proprietary microplates and biocompatible hydrogel technology for diabetes treatment
likarda.com →- Grants
- $513K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 11
- 1 granted · 10 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Clinical grade insulin-producing iPSCs encapsulated with durable hyaluronic acid for long-term treatment of type 1 diabetes | $256,338 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Clinical grade insulin-producing iPSCs encapsulated with durable hyaluronic acid for long-term treatment of type 1 diabetes | $256,338 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1983 | POP ART, INC. | — | $1.0M |
| 1984 | NEURAEGIS INC | — | — |
| 1985 | C4 Therapeutics | — | $70M |
| 1986 | LIKARDA LLC | — | — |
| 1987 | NATURA THERAPEUTICS, INC. | — | — |
| 1988 | Ultimaxx Health, LLC | — | $10M |
| 1989 | LIGHT SWITCH BIO, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Hydrogel Microparticle-based Soft Tissue Fillersapplication
- Hydrogel Microparticle-based Lubricantapplication
- Microencapsulation Technique And Products Thereofgranted
- Hydrogel Microparticle-based Lubricantapplication
- Hydrogel Microparticle-based Lubricantapplication
- Tunable Degradation In Hydrogel Microparticlesapplication
- Tunable Degradation In Hydrogel Microparticlesapplication
- Microencapsulation Technique And Products Thereofapplication
- Microencapsulation Technique And Products Thereofapplication
- Hydrogel Microparticle-based Soft Tissue Fillersapplication
- Hydrogel Microparticle-based Dermal Fillersapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.